Diabetes and Obesity Panel
The Diabetes-Obesity Panel examines 56 genes associated with Diabetes and obesity. Patients identified with a disease-causing change in a gene may benefit from increased surveillance, targeted and personalized management, and preventative steps to better manage their risk. Medical intervention can include lifestyle changes in diet and exercise, hormone replacement, and bariatric surgery. If a pathogenic variant is identified in a patient, close relatives are up to 50% more likely to be at increased risk.
Testing is for patients with a personal or family history suggestive of monogenic diabetes and obesity-related disorders. These conditions may occur independently or as clinical features of a genic syndrome.